Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
Australian man sentenced to 13 years in Russian-controlled Ukraine for fighting alongside Ukrainian forces, sparking diplomatic tensions.
Russian cyberattacks disrupt Polish election, highlighting concerns about foreign interference in democratic processes.
Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
Australian man sentenced to 13 years in Russian-controlled Ukraine for fighting alongside Ukrainian forces, sparking diplomatic tensions.
Russian cyberattacks disrupt Polish election, highlighting concerns about foreign interference in democratic processes.